FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3083440031> ?p ?o ?g. }

• W3083440031 endingPage "133.e8" @default.
• W3083440031 startingPage "133.e1" @default.
• W3083440031 abstract "To evaluate pathologic downstaging after radical cystectomy and pelvic lymph node dissection for clinically lymph node positive urothelial bladder cancer and to determine optimal preoperative imaging variables in predicting pathologic nodal status. We identified all patients with clinically lymph node positive urothelial bladder cancer who underwent radical cystectomy and extended pelvic lymph node dissection with intent to cure at our institution. Patients were stratified based on pathologic node status to determine clinical associations and survival outcomes. Pre and post-chemotherapy CT scans were reviewed to characterize lymph node size and morphology. We also sought to determine associations between post-chemotherapy radiology variables and pathologic response. We identified 130 patients with clinically node positive bladder cancer, out of which 76 (58.5%) received induction chemotherapy. Thirty three (43.4%) had pathologic T downstaging following chemotherapy, compared to 7 (12.9%) patients who had surgery alone (P< 0.0001). A complete nodal response (pN0) occurred in 31 (40.8%) patients post-chemotherapy, while 6 (11.1%) of those who received cystectomy alone ended up being pN0 (P< 0.0001). Median overall survival and recurrence-free survival were shorter in patients with pN+ versus pN0 disease (1.9 years vs. 12.8 years, P= 0.016 and 1.2 years vs. 4.3 years, P= 0.013, respectively). Review of 29 post chemotherapy CT scans showed that patients with pathologic nodal involvement had a greater median number of enlarged nodes (3.5 vs. 1, P= 0.038) and a greater median size of largest node (8.5 mm vs. 6.0 mm, P= 0.021) on imaging compared to those with complete pN0. Each 1 mm increase in size of the largest node on post-chemotherapy CT scan increased the chance of having pN+ disease by 1.57 (95% CI 1.02–2.44, P= 0.043). Using a median node size of 8 mm as a cut-off to predict pN+ disease provided a sensitivity and specificity of 72% and 80%, respectively (c-index = 0.761, P= 0.014). The positive predictive value for this cut-off was 87% (95% CI 58%–98%) and negative predictive value was 62% (32%–85%). Patients with clinically node positive bladder cancer may have significant pN0 after induction chemotherapy. Our data suggest a post-chemotherapy CT scan with an 8 mm nodal size cut-off may be a better predictor of pathologic nodal status than more traditional measures." @default.
• W3083440031 created "2020-09-11" @default.
• W3083440031 creator A5016703557 @default.
• W3083440031 creator A5033959530 @default.
• W3083440031 creator A5046763596 @default.
• W3083440031 creator A5047209764 @default.
• W3083440031 creator A5047940829 @default.
• W3083440031 creator A5055469834 @default.
• W3083440031 creator A5063174892 @default.
• W3083440031 creator A5064421115 @default.
• W3083440031 creator A5067558680 @default.
• W3083440031 creator A5069776586 @default.
• W3083440031 creator A5077869260 @default.
• W3083440031 date "2021-02-01" @default.
• W3083440031 modified "2023-10-02" @default.
• W3083440031 title "Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response" @default.
• W3083440031 cites W1571740234 @default.
• W3083440031 cites W1950976180 @default.
• W3083440031 cites W1975918912 @default.
• W3083440031 cites W1999296223 @default.
• W3083440031 cites W2005330325 @default.
• W3083440031 cites W2019607817 @default.
• W3083440031 cites W2026291233 @default.
• W3083440031 cites W2038228630 @default.
• W3083440031 cites W2039259046 @default.
• W3083440031 cites W2079593937 @default.
• W3083440031 cites W2090241022 @default.
• W3083440031 cites W2101562875 @default.
• W3083440031 cites W2113156769 @default.
• W3083440031 cites W2117427924 @default.
• W3083440031 cites W2177967294 @default.
• W3083440031 cites W2373606074 @default.
• W3083440031 cites W2413134876 @default.
• W3083440031 cites W2462649057 @default.
• W3083440031 cites W2511170084 @default.
• W3083440031 cites W2539504178 @default.
• W3083440031 cites W2556072171 @default.
• W3083440031 cites W2609787832 @default.
• W3083440031 cites W2618461063 @default.
• W3083440031 cites W2621004257 @default.
• W3083440031 cites W2725189438 @default.
• W3083440031 cites W2792304613 @default.
• W3083440031 cites W2808326981 @default.
• W3083440031 cites W2896629424 @default.
• W3083440031 doi "https://doi.org/10.1016/j.urolonc.2020.08.020" @default.
• W3083440031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32900621" @default.
• W3083440031 hasPublicationYear "2021" @default.
• W3083440031 type Work @default.
• W3083440031 sameAs 3083440031 @default.
• W3083440031 citedByCount "5" @default.
• W3083440031 countsByYear W30834400312022 @default.
• W3083440031 countsByYear W30834400312023 @default.
• W3083440031 crossrefType "journal-article" @default.
• W3083440031 hasAuthorship W3083440031A5016703557 @default.
• W3083440031 hasAuthorship W3083440031A5033959530 @default.
• W3083440031 hasAuthorship W3083440031A5046763596 @default.
• W3083440031 hasAuthorship W3083440031A5047209764 @default.
• W3083440031 hasAuthorship W3083440031A5047940829 @default.
• W3083440031 hasAuthorship W3083440031A5055469834 @default.
• W3083440031 hasAuthorship W3083440031A5063174892 @default.
• W3083440031 hasAuthorship W3083440031A5064421115 @default.
• W3083440031 hasAuthorship W3083440031A5067558680 @default.
• W3083440031 hasAuthorship W3083440031A5069776586 @default.
• W3083440031 hasAuthorship W3083440031A5077869260 @default.
• W3083440031 hasConcept C121608353 @default.
• W3083440031 hasConcept C126322002 @default.
• W3083440031 hasConcept C126838900 @default.
• W3083440031 hasConcept C126894567 @default.
• W3083440031 hasConcept C141071460 @default.
• W3083440031 hasConcept C143998085 @default.
• W3083440031 hasConcept C2775862295 @default.
• W3083440031 hasConcept C2775910329 @default.
• W3083440031 hasConcept C2776694085 @default.
• W3083440031 hasConcept C2780352672 @default.
• W3083440031 hasConcept C2780849966 @default.
• W3083440031 hasConcept C71924100 @default.
• W3083440031 hasConceptScore W3083440031C121608353 @default.
• W3083440031 hasConceptScore W3083440031C126322002 @default.
• W3083440031 hasConceptScore W3083440031C126838900 @default.
• W3083440031 hasConceptScore W3083440031C126894567 @default.
• W3083440031 hasConceptScore W3083440031C141071460 @default.
• W3083440031 hasConceptScore W3083440031C143998085 @default.
• W3083440031 hasConceptScore W3083440031C2775862295 @default.
• W3083440031 hasConceptScore W3083440031C2775910329 @default.
• W3083440031 hasConceptScore W3083440031C2776694085 @default.
• W3083440031 hasConceptScore W3083440031C2780352672 @default.
• W3083440031 hasConceptScore W3083440031C2780849966 @default.
• W3083440031 hasConceptScore W3083440031C71924100 @default.
• W3083440031 hasIssue "2" @default.
• W3083440031 hasLocation W30834400311 @default.
• W3083440031 hasOpenAccess W3083440031 @default.
• W3083440031 hasPrimaryLocation W30834400311 @default.
• W3083440031 hasRelatedWork W1989626086 @default.
• W3083440031 hasRelatedWork W1999937677 @default.
• W3083440031 hasRelatedWork W2050296411 @default.
• W3083440031 hasRelatedWork W2143325930 @default.
• W3083440031 hasRelatedWork W2169777401 @default.
• W3083440031 hasRelatedWork W2396742367 @default.

• next